Literature DB >> 16288895

Elements of diabetic nephropathy in a patient with GLUT 2 deficiency.

Gerard T Berry1, John W Baynes, Kevin J Wells-Knecht, Benjamin S Szwergold, René Santer.   

Abstract

The Fanconi-Bickel syndrome is caused by homozygosity or compound heterozygosity for mutations of the facilitated glucose transporter 2 gene (GLUT2). Glycogen accumulates in renal tubular cells and they fail to reabsorb multiple filtered solutes because of impairment in GLUT2-mediated efflux of glucose. We describe a 10-year-old male child with GLUT2 deficiency who produced massive amounts of 3-deoxyfructose (3-DF) in the kidneys. Since 3-DF is a detoxification product of a potent glycating agent, 3-deoxyglucosone, a precursor of advanced glycation end-products, this suggests a massive accumulation of glucose within tubular cells probably as a consequence of GLUT2 deficiency. The level of 3-DF in the urine of this atypical patient, who also manifested renal glomerular hyperfiltration, microalbuminuria, and glomerular mesangial expansion, was higher than in any patient examined with diabetes mellitus. Elevated levels of glucose and/or its metabolites in renal tubular cells may be necessary but not sufficient for the development of both the renal tubulopathy and diabetic-like glomerular disease in GLUT2 deficiency.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16288895     DOI: 10.1016/j.ymgme.2005.09.010

Source DB:  PubMed          Journal:  Mol Genet Metab        ISSN: 1096-7192            Impact factor:   4.797


  5 in total

1.  Phenotypic variability in patients with fanconi-bickel syndrome with identical mutations.

Authors:  Elena Fridman; Avraham Zeharia; Tal Markus-Eidlitz; Yishai Haimi Cohen
Journal:  JIMD Rep       Date:  2014-04-10

2.  The effect of gonadotropin on glucose transport and apoptosis in rat ovary.

Authors:  Cheng Zhang; Wanbao Niu; Zhengpin Wang; Xiaoxia Wang; Guoliang Xia
Journal:  PLoS One       Date:  2012-08-01       Impact factor: 3.240

Review 3.  Glucose transporters in adipose tissue, liver, and skeletal muscle in metabolic health and disease.

Authors:  Alexandra Chadt; Hadi Al-Hasani
Journal:  Pflugers Arch       Date:  2020-06-26       Impact factor: 3.657

4.  Advanced glycation end products and the absence of premature atherosclerosis in glycogen storage disease Ia.

Authors:  N C den Hollander; D J Mulder; R Graaff; S R Thorpe; J W Baynes; G P A Smit; A J Smit
Journal:  J Inherit Metab Dis       Date:  2007-06-14       Impact factor: 4.982

5.  Loss of sugar detection by GLUT2 affects glucose homeostasis in mice.

Authors:  Emilie Stolarczyk; Maude Le Gall; Patrick Even; Anne Houllier; Patricia Serradas; Edith Brot-Laroche; Armelle Leturque
Journal:  PLoS One       Date:  2007-12-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.